Vivus VVUS

  1. All
  2. Commentary
  3. Headlines
    1. UPDATE 2-Top Vivus shareholder plans to buy company in $640 mln deal

      Headlines

      Wed, 28 May 2014

      May 28 (Reuters) - Vivus Inc's biggest shareholder said it was planning to buy the obesity drug maker in a deal valued at $640 million, the latest shareholder attempt to revive a company that has...

    2. Vivus shareholder Aspen plans to buy company for $640 mln

      Headlines

      Wed, 28 May 2014

      May 28 (Reuters) - Aspen Investment Fund, a shareholder of obesity drug maker Vivus Inc, said it was planning to offer to buy the company for $640 million.

    3. From Barron's Nov 18 (Part 2)

      Commentary

      Sat, 16 Nov 2013

      NB: My on-line Barrons appears incomplete for the last two weeks, omitting such regular columns as Insider Trades. My paper Barron's reports insiders accumulating shares of CUDA, TCS, NLY, SCAI, VVUS , AWH and OCRX.

    4. Top Vivus shareholder says proxy firm ISS backs 3 of 9 board nominees

      Headlines

      Fri, 5 Jul 2013

      July 5 (Reuters) - Vivus Inc's largest shareholder, First Manhattan Co, said on Friday proxy advisory firm Institutional Shareholder Services recommended three of the nine directors the shareholder...

    5. UPDATE 1-Top Vivus holder proposes ex AstraZeneca exec as CEO

      Headlines

      Tue, 2 Jul 2013

      NEW YORK, July 2 (Reuters) - Vivus Inc's largest shareholder on Tuesday took the unusual step of naming the man it would install as the drugmaker's chief executive should it prevail in its battle to...

    6. Vivus's top shareholder proposes former AstraZeneca exec as CEO

      Headlines

      Tue, 2 Jul 2013

      July 2 (Reuters) - Vivus Inc's largest shareholder First Manhattan Co said it proposed a former senior executive of AstraZeneca Plc as chief executive of the obesity drug maker, a move that could...

    7. Denner added as nominee to Vivus board by activist investor

      Headlines

      Thu, 23 May 2013

      (Reuters) - First Manhattan Company (FMC) added some heavyweight muscle on Thursday to its bid to shake up the board of drugmaker Vivus Inc by naming former Carl Icahn top lieutenant Alex Denner and...

    8. UPDATE 1- Vivus gets FDA nod to sell diet pill via retail pharmacies

      Headlines

      Tue, 16 Apr 2013

      * Plans to launch direct-to-consumer campaign later this year

    9. UPDATE 1-Risk plan change not enough for Vivus drug success: top investor

      Headlines

      Wed, 10 Apr 2013

      April 10 (Reuters) - An expected revision of Vivus Inc's risk management plan for its obesity drug Qsymia is unlikely to guarantee the drug's success, the company's top shareholder said.

    10. First Manhattan seeks seats on Vivus board as diet drug founders

      Headlines

      Fri, 8 Mar 2013

      (Reuters) - The board of directors of Vivus Inc is under attack from one of its biggest investors following the disappointing launch of a diet pill that has helped drive the company's shares down 63...

    « Prev1234Next »
    Content Partners